OpenBilldrug price receipt

NADAC week of 2026-10-14

CLINDAMYCIN PHOS 1% PLEDGET

For 1 unit (EA)

Pharmacies pay

$0.29 filed

1 × $0.28544 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$5.33 estimated

$0.29 + $0.04 (15%) + $5.00 fee per fill = $5.33

This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

CLINDAMYCIN PHOS 1% PLEDGET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “clindamycin phosphate” and “clindamycin phosphate topical”, as its NDCs’ listings variously write the nonproprietary name.

FDA gives its dosage form as solution and its route as topical.

FDA lists 4 labelers (the companies named on the label) for its NDCs, among them Rising Pharma Holdings, Inc., Padagis Israel Pharmaceuticals Ltd and i3 Pharmaceuticals, LLC.

FDA’s Established Pharmacologic Class for it is Lincosamide Antibacterial.

The NADAC file of 2026-10-14 prices it under 4 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $0.29 for 1 unit (EA) (1 × $0.28544 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.

All 4 NDCs

Other strengths, forms and brands

11 other products in the NADAC file share an FDA nonproprietary name with CLINDAMYCIN PHOS 1% PLEDGET.

ProductPharmacies pay per unitMedicare per unit
CLEOCIN 2% VAGINAL CREAM
brand · cream
$1.79228 per GM filed
eff. 2026-09-23
We don’t know yet
CLEOCIN 100 MG VAGINAL OVULE
brand · suppository
$60.17905 per EA filed
eff. 2026-09-23
We don’t know yet
CLINDACIN 1% FOAM
generic · aerosol, foam
$1.83049 per GM filed
eff. 2026-09-23
$3.23058 per GM filed
Part D 2024 average
CLINDAMYCIN 2% VAGINAL CREAM
generic · cream
$1.85916 per GM filed
eff. 2026-09-23
We don’t know yet
CLINDAMYCIN PH 1% GEL
generic · gel
$0.13074 to $0.14236 per GM filed
eff. 2026-09-23
We don’t know yet
CLINDAMYCIN PH 1% SOLUTION
generic · solution
$0.14989 to $0.1788 per ML filed
eff. 2026-09-23
We don’t know yet
CLINDAMYCIN PHOS 1% PLEDGET this page
generic · solution
$0.28544 per EA filed
eff. 2026-09-23
We don’t know yet
CLINDAMYCIN PHOSP 1% LOTION
generic · lotion
$0.24475 per ML filed
eff. 2026-09-23
We don’t know yet
CLINDAMYCIN PHOSPHATE 1% FOAM
generic · aerosol, foam
$1.83049 to $2.20962 per GM filed
eff. 2026-09-23
We don’t know yet
CLINDAMYCIN PHOSPHATE 1% GEL
generic · gel
$3.40149 per ML filed
eff. 2026-09-23
We don’t know yet
CLINDESSE 2% VAGINAL CREAM
brand · cream
$26.6211 per GM filed
eff. 2026-09-23
$27.16372 per GM filed
Part D 2024 average
XACIATO 2% VAGINAL GEL
brand · gel
$18.86864 per GM filed
eff. 2026-09-23
$19.3401 per GM filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 4 NDCs’ NADAC prices is $0.28544 per EA filed.

Of the 4 other products in FDA’s Lincosamide Antibacterial class priced per EA, 1 has a higher middle NADAC price and 3 a lower one. The one in the middle is CLINDAMYCIN HCL 300 MG CAPSULE, at $0.17458 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why does this page start at 1 unit (EA)?
NADAC prices this product per EA, and the FDA NDC Directory lists its 4 NDCs as dosage form “SOLUTION” with route “TOPICAL”. Only a tablet, capsule, lozenge or troche with route “ORAL”, or a tablet or film with route “SUBLINGUAL” or “BUCCAL”, starts at 30, and none of these is one. NADAC’s EA for it may be a whole package (such as a kit, pen, syringe, vial or inhaler) or one dose inside it, and the files do not say which. So the card starts at 1 unit (EA) rather than guess how many make up a fill; change it to match your prescription.